You've just added:

May 01, 2017

Advancing a First-in-Class Small Molecule Therapeutic that Inhibits an Enzymatic Regulator of Pathways Essential for the Growth and Spread of Cancer

John Letterio, MD - 2017 Harrington Scholar-Innovator

About the Scholar

John Letterio

Immunology, Neuroscience, Oncology

John Letterio, MD

Case Western Reserve University
2017 Harrington Scholar-Innovator

More about John Letterio